Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comOver the last two decades, an improved understanding of the role that genetics plays in health and disease has revolutionized approaches to precision medicine. From innovations in gene-editing technologies, such as CRISPR, to referencing large-scale genetic repositories and predicting hereditary disease risk, healthcare providers are beginning to leverage detailed patient profiles and emerging technologies to optimize treatment outcomes.Metabolomics is the newest addition to the "omics" disciplines and is showing a rapid growth in its application to human health research because of fundamental advancements in measurement and analysis techniques. Metabolomics has unique and proven advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. Driven by such innovation, the genetic diagnostics market is expected to reach $2.5 billion by 2030 at a CAGR of 13.94 percent. To put the spotlight on such key developments in the industry, Healthcare Tech Outlook illustrates how the genetic diagnostics space is leveraging a game plan for the genetic diagnostics space. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Derya Dilek Kançai, Ph.D., Laboratory Manager at Acibadem Labcell Cellular Therapy Center; Karen Dale, Chief Diversity, Equity, and Inclusion Officer at AmeriHealth Caritas Family of Companies; and Roberta Harbison, Sterile Processing Director at AtlantiCare Regional Medical Center. They shed light on the future of immunotherapy, setting a game plan for equity in the future, and medical device reprocessors--the unsung heroes in the healthcare industry. In this edition of Healthcare Tech Outlook, we also bring to you the story of the top genetic diagnostics solution providers. In the list, ADS Biotec stands out for its robust solutions that can solve the service challenges for laboratories with its game-changing solutions and cost-effective automation. They cover the full cytogenetic sample preparation process, from chromosome harvesting to slide preparation and slide staining, supplying a full range of automation systems.Through the following pages, we aim to shine a light on the innovative trends and latest developments in the genetic diagnostics industry. We would like to know your thoughts.Metabolomics: The New Frontier in Genetic TestingEditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark Robert Wilson BrunoVega StanleyDavis MillsDebbie WillisVisualizerUTLOOKHealthcare Tech Copyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comMichael WayneChris LynnFebruary - 2023, volume 09 - Issue 01 Published by ValleyMedia, Inc. (ISSN 2691 - 3933)To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech
< Page 5 | Page 7 >